Building and characterizing antibody-targeted lipidic nanotherapeutics

Methods in Enzymology

Volumn 502, Issue , 2012, Pages 139-166

  Kirpotin, Dmitri B ^a   Noble, Charles O ^a   Hayes, Mark E ^a   Huang, Zhaohua ^a   Kornaga, Tad ^a   Zhou, Yu ^b   Nielsen, Ulrik B ^a   Marks, James D ^b   Drummond, Daryl C ^a  

^a MERRIMACK PHARMACEUTICALS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTIBODY; CAMPTOTHECIN DERIVATIVE; CYSTEINE; HISTONE DEACETYLASE INHIBITOR; IMIDAZOLE; IMMUNOLIPOSOME; LIPOSOME; MACROGOL; PHOSPHATIDYLETHANOLAMINE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SUCROSOFATE; TOPOTECAN; VINCA ALKALOID;

ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; DRUG STABILITY; HYDROLYSIS; IN VIVO STUDY; NANOENCAPSULATION; NANOENGINEERING; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN PURIFICATION; TEMPERATURE;

EID: 84855401857     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-416039-2.00007-0     Document Type: Chapter

References (45)

1. T.M. Allen, W.W. Cheng, J.I. Hare, and K.M. Laginha Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer Anticancer Agents Med. Chem. 6 2006 513 523 (Pubitemid 44697110)
2. G.R. Bartlett Phosphorous assay in column chromatography J. Biol. Chem. 234 1959 466 468
3. B. Becerril, M.A. Poul, and J.D. Marks Toward selection of internalizing antibodies from phage libraries Biochem. Biophys. Res. Commun. 255 1999 386 393 (Pubitemid 29292269)
4. P. Carter, R.F. Kelley, M.L. Rodrigues, B. Snedecor, M. Covarrubias, M.D. Velligan, W.L. Wong, A.M. Rowland, C.E. Kotts, and M.E. Carver High level Escherichia coli expression and production of a bivalent humanized antibody fragment Biotechnology (N. Y.) 10 1992 163 167
5. G.J. Charrois, and T.M. Allen Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer Biochim. Biophys. Acta. 1663 2004 167 177 (Pubitemid 38625591)
6. D.C. Drummond, O. Meyer, K. Hong, D.B. Kirpotin, and D. Papahadjopoulos Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors Pharmacol. Rev. 51 1999 691 743
7. D.C. Drummond, D.B. Kirpotin, and K. Hong Liposomes Useful for Drug Delivery 2005 (United States)
8. D.C. Drummond, C. Marx, Z. Guo, G. Scott, C. Noble, D. Wang, M. Pallavicini, D.B. Kirpotin, and C.C. Benz Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes Clin. Cancer Res. 11 2005 3392 3401 (Pubitemid 40627892)
9. D.C. Drummond, C.O. Noble, Z. Guo, K. Hong, J.W. Park, and D.B. Kirpotin Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy Cancer Res. 66 2006 3271 3277
10. D.C. Drummond, C.O. Noble, M.E. Hayes, J.W. Park, and D.B. Kirpotin Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development J. Pharm. Sci. 97 2008 4696 4740
11. D.C. Drummond, C.O. Noble, Z. Guo, M.E. Hayes, J.W. Park, C.J. Ou, Y.L. Tseng, K. Hong, and D.B. Kirpotin Improved pharmacokinetics and efficacy of a highly stable nanoliposomal vinorelbine J. Pharmacol. Exp. Ther. 328 2009 321 330
12. D.C. Drummond, C.O. Noble, Z. Guo, M.E. Hayes, C. Connolly-Ingram, B.S. Gabriel, B. Hann, B. Liu, J.W. Park, K. Hong, C.C. Benz, and J.D. Marks Development of a highly stable and targetable nanoliposomal formulation of topotecan J. Control. Release 141 2010 13 21
13. D.B. Fenske, and P.R. Cullis Entrapment of small molecules and nucleic acid-based drugs in liposomes Methods Enzymol. 391 2005 7 40 (Pubitemid 40254027)
14. A. Gabizon, R. Catane, B. Uziely, B. Kaufman, and T. Safra Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes Cancer Res. 54 1994 987 992 (Pubitemid 24085451)
15. G. Haran, R. Cohen, L.K. Bar, and Y. Barenholz Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphiphathic weak bases Biochim. Biophys. Acta. 1151 1993 201 215 (Pubitemid 23283973)
16. J.A. Harding, C.M. Engbers, M.S. Newman, N.I. Goldstein, and S. Zalipsky Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes Biochim. Biophys. Acta. 1327 1997 181 192 (Pubitemid 27300135)
17. M.E. Hayes, D.C. Drummond, D.B. Kirpotin, W.W. Zheng, C.O. Noble, J.W. Park, J.D. Marks, C.C. Benz, and K. Hong Genospheres: Self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery Gene Ther. 13 2006 646 651
18. Z. Huang, J.I. Park, D.S. Watson, P. Hwang, and F.C. Szoka Jr. Facile synthesis of multivalent nitrilotriacetic acid (NTA) and NTA conjugates for analytical and drug delivery applications Bioconjug. Chem. 17 2006 1592 1600 (Pubitemid 44851506)
19. Z. Huang, P. Hwang, D.S. Watson, L. Cao, and F.C. Szoka Jr. Tris-nitrilotriacetic acids of subnanomolar affinity toward hexahistidine tagged molecules Bioconjug. Chem. 20 2009 1667 1672
20. D. Kirpotin, J.W. Park, K. Hong, S. Zalipsky, W.-L. Li, P. Carter, C.C. Benz, and D. Papahadjopoulos Sterically stabilized anti-HER2 immunoliposomes: Design and targeting to human breast cancer cells in vitro Biochemistry 36 1997 66 75 (Pubitemid 27024679)
21. D.B. Kirpotin, D.C. Drummond, Y. Shao, M.R. Shalaby, K. Hong, U.B. Nielsen, J.D. Marks, C.C. Benz, and J.W. Park Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66 2006 6732 6740 (Pubitemid 44085631)
22. C. Mamot, D.C. Drummond, C.O. Noble, V. Kallab, Z. Guo, K. Hong, D.B. Kirpotin, and J.W. Park Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo Cancer Res. 65 2005 11631 11638 (Pubitemid 41821723)
23. B.L.-S. Mui, P.R. Cullis, E.A. Evans, and T.D. Madden Osmotic properties of large unilamellar vesicles prepared by extrusion Biophys. J. 64 1993 443 453 (Pubitemid 23093857)
24. B.L.-S. Mui, P.R. Cullis, P.H. Pritchard, and T.D. Madden Influence of plasma on the osmotic sensitivity of large unilamellar vesicles prepared by extrusion J. Biol. Chem. 269 1994 7364 7370 (Pubitemid 24217933)
25. D.F. Nellis, D.L. Ekstrom, D.B. Kirpotin, J. Zhu, R. Andersson, T.L. Broadt, T.F. Ouellette, S.C. Perkins, J.M. Roach, D.C. Drummond, K. Hong, and J.D. Marks Preclinical manufacture of an anti-HER2 scFv-PEG-DSPE, liposome-inserting conjugate. 1. Gram-scale production and purification Biotechnol. Prog. 21 2005 205 220 (Pubitemid 40218491)
26. D.F. Nellis, S.L. Giardina, G.M. Janini, S.R. Shenoy, J.D. Marks, R. Tsai, D.C. Drummond, K. Hong, J.W. Park, T.F. Ouellette, S.C. Perkins, and D.B. Kirpotin Preclinical manufacture of anti-HER2 liposome-inserting, scFv-PEG-lipid conjugate. 2. Conjugate micelle identity, purity, stability, and potency analysis Biotechnol. Prog. 21 2005 221 232 (Pubitemid 40218492)
27. U.B. Nielsen, D.B. Kirpotin, E.M. Pickering, K. Hong, J.W. Park, M. Refaat Shalaby, Y. Shao, C.C. Benz, and J.D. Marks Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis Biochim. Biophys. Acta. 1591 2002 109 118 (Pubitemid 35232074)
28. U.B. Nielsen, D.B. Kirpotin, E.M. Pickering, D.C. Drummond, and J.D. Marks A novel assay for monitoring internalization of nanocarrier coupled antibodies BMC Immunol. 7 2006 24
29. C.O. Noble, D.B. Kirpotin, M.E. Hayes, C. Mamot, K. Hong, J.W. Park, C.C. Benz, J.D. Marks, and D.C. Drummond Development of ligand-targeted liposomes for cancer therapy Expert Opin. Ther. Targets 8 2004 335 353 (Pubitemid 39117698)
30. C.O. Noble, Z. Guo, M.E. Hayes, J.D. Marks, J.W. Park, C.C. Benz, D.B. Kirpotin, and D.C. Drummond Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine Cancer Chemother. Pharmacol. 64 2009 741 751
31. N. Ostrowsky Liposome size measurements by photon correlation spectroscopy Chem. Phys. Lipids 64 1993 45 56 (Pubitemid 23290865)
32. G. Pagnan, D. Stuart, F. Pastorino, L. Raffaghello, P. Montaldo, T. Allen, B. Caabretta, and B. Ponzoni Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells vis disialoganglioside GD2-targeted immunoliposomes: Antitumor effects J. Natl. Cancer Inst. 92 2000 253 261 (Pubitemid 30099785)
33. J.W. Park, K. Hong, D.B. Kirpotin, G. Colbern, R. Shalaby, J. Baselga, Y. Shao, U.B. Nielsen, J.D. Marks, D. Moore, D. Papahadjopoulos, and C.C. Benz Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery Clin. Cancer Res. 8 2002 1172 1181 (Pubitemid 35177372)
34. M.J. Parr, S.M. Ansell, L.S. Choi, and P.R. Cullis Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles Biochim. Biophys. Acta. 1195 1994 21 30 (Pubitemid 24318087)
35. M.A. Poul, B. Becerril, U.B. Nielsen, P. Morisson, and J.D. Marks Selection of tumor-specific internalizing human antibodies from phage libraries J. Mol. Biol. 301 2000 1149 1161
36. L. Raffaghello, G. Pagnan, F. Pastorino, E. Cosimo, C. Brignole, D. Marimpietri, P.G. Montaldo, C. Gambini, T.M. Allen, E. Bogenmann, and M. Ponzoni In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma Int. J. Cancer 104 2003 559 567 (Pubitemid 36337255)
37. P. Sapra, and T.M. Allen Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs Cancer Res. 62 2002 7190 7194 (Pubitemid 36025236)
38. P. Sapra, and T.M. Allen Ligand-targeted liposomal anticancer drugs Prog. Lipid Res. 42 2003 439 462 (Pubitemid 36700404)
39. P. Sapra, P. Tyagi, and T.M. Allen Ligand-targeted liposomes for cancer treatment Curr. Drug Deliv. 2 2005 369 381 (Pubitemid 41277769)
40. P.H. Stahl, and C.G. Wermuth Monographs on acids and bases Handbook of Pharmaceutical Salts: Properties, Selection, and Use 2002 Wiley-VCH Weiheim 265 327 (2002)
41. M. Sugano, N.K. Egilmez, S.J. Yokota, F.A. Chen, J. Harding, S.K. Huang, and R.B. Bankert Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice Cancer Res. 60 2000 6942 6949 (Pubitemid 32059167)
42. A.S. Taggar, J. Alnajim, M. Anantha, A. Thomas, M. Webb, E. Ramsay, and M.B. Bally Copper-topotecan complexation mediates drug accumulation into liposomes J. Control. Release 114 2006 78 88 (Pubitemid 44128628)
43. W.C. Zamboni, S. Strychor, E. Joseph, D.R. Walsh, B.A. Zamboni, R.A. Parise, M.E. Tonda, N.Y. Yu, C. Engbers, and J.L. Eiseman Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts Clin. Cancer Res. 13 2007 7217 7223 (Pubitemid 350276909)
44. Y. Zhou, and J.D. Marks Identification of target and function specific antibodies for effective drug delivery Methods Mol. Biol. 525 2009 145 160 xv
45. Y. Zhou, H. Zou, S. Zhang, and J.D. Marks Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigens J. Mol. Biol. 404 2010 88 99